Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Supplementary Materials and Methods from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
View through CrossRef
<p>Supplementary materials and methods</p>
American Association for Cancer Research (AACR)
Title: Supplementary Materials and Methods from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Description:
<p>Supplementary materials and methods</p>.
Related Results
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
<div>Abstract<p>Angiosarcoma is a malignant vascular tumor originating from endothelial cells of blood vessels or lymphatic vessels. The specific driver mutations in an...
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
<div>Abstract<p>Angiosarcoma is a malignant vascular tumor originating from endothelial cells of blood vessels or lymphatic vessels. The specific driver mutations in an...
Supplemental Tables S1-S6 from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Supplemental Tables S1-S6 from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
<p>Supplementary tables S1-S6: The results of the gene expression analysis as determined by the paired-end transcriptome sequences (S1); The results of the expression analysi...
The Nuclear Fusion Award
The Nuclear Fusion Award
The Nuclear Fusion Award ceremony for 2009 and 2010 award winners was held during the 23rd IAEA Fusion Energy Conference in Daejeon. This time, both 2009 and 2010 award winners w...
Personalized Treatment for Scalp Angiosarcoma
Personalized Treatment for Scalp Angiosarcoma
Cutaneous angiosarcoma is a rare and aggressive malignant tumor that originates from the endothelial cells of blood vessels or lymphatic vessels. More than half of cutaneous angios...
Nonproliferation and fusion power plants
Nonproliferation and fusion power plants
Abstract
The world now appears to be on the brink of realizing commercial fusion. As fusion energy progresses towards near-term commercial deployment, the question arises a...
Multicentric Epithelioid Angiosarcoma of Bone
Multicentric Epithelioid Angiosarcoma of Bone
Bone epithelioid angiosarcoma is rare and generally shows positive immunostaining for epithelial markers. Multicentric bone epithelioid angiosarcoma is easily misdiagnosed as carci...